跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
tolerizing immune modifying nanoparticles
首页
药物
tolerizing immune modifying nanoparticles
tolerizing immune modifying nanoparticles
未知生产厂商
订阅
生成 AI 研报
Share to Twitter
Share to Facebook
Share to LinkedIn
Share to Reddit
摘要
临床试验
审批记录
专利
每项发明一条,涵盖美国、欧洲、PCT 与中国的同族专利。
PREPARATION OF TOLERIZING NANOPARTICLES FOR THE TREATMENT OF PEANUT ALLERGY
EP 4436557 A4
申请人: COUR PHARMACEUTICALS DEV COMPANY INC
优先权: 2021
EP
US
2 件公开
TOLERIZING IMMUNE MODIFYING NANOPARTICLES FOR MYASTHENIA GRAVIS TREATMENT
EP 4687970 A1
申请人: COUR PHARMACEUTICALS DEV COMPANY INC
优先权: 2023
EP
WO
2 件公开
PREPARATION OF TOLERIZING NANOPARTICLES FOR THE TREATMENT OF PRIMARY BILIARY CHOLANGITIS
EP 4716528 A1
申请人: COUR PHARMACEUTICALS DEV COMPANY INC
优先权: 2023
EP
WO
2 件公开
TREATMENT OF TYPE 1 DIABETES (T1D) WITH TOLERIZING NANOPARTICLES
EP 4719464 A1
申请人: COUR PHARMACEUTICALS DEV COMPANY INC
优先权: 2023
EP
WO
2 件公开
Tolerizing Immune Modifying Nanoparticles for Overcoming the Immunogenicity of Therapeutic Vectors and Proteins
US 20250367274 A1
申请人: COUR PHARMACEUTICALS DEV COMPANY INC
优先权: 2023
US
TOLERIZING IMMUNE MODIFYING NANOPARTICLES FOR TREATMENT OF ALPHA GAL SYNDROME
WO 2026015713 A1
申请人: UNIV MICHIGAN REGENTS
优先权: 2024
WO
TOLERIZING IMMUNE MODIFYING NANOPARTICLES FOR TREATMENT OF NARCOLEPSY
WO 2026019942 A3
申请人: COUR PHARMACEUTICALS DEV COMPANY INC
优先权: 2024
WO
药物
反馈